Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.

Noma A, Yokosuka T, Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis 1983;49: 1-7.

Rosseneu M, Vercaemst R, Vinaimont N, Van Tomont P, Henderson LO, Herbert PN. Quantitative determination of human plasma apolipoprotein Al by laser immunonephelometry. Clin Chem 1981;27:856-9.

Rosseneu M, Vinaimont R, Dekeersgieter W, Belpaire F. Standardisation of immunoassays for the quantitation of plasma apoB protein. Anal Biochem 1981:116:204-10.

Funke H, Assman G. Influence of triglyceride-rich lipoproteins in nephelometric determination of apolipoprotein Al. Clin Chem 1982;28:1 153-8.

Heuck CC, Schlief G. Nephelometry of apolipoprotein B in human serum. Clin Chem 1970;25:221-6.

Van Stiphout WAHJ, Hofman A, Kruijssen HACM, Vermeeren R, Groot PHE. Is the ratio of apoB/apoA I an early predictor of coronary atherosclerosis? Atherosclerosis 1986;62:179-82.